Abstract
Compositions having amylin or an amylin agonist and a glucagon compound, particularly peptide compounds, for the control of glucose production in mammals are provided. The compositions are useful in the treatment of hypoglycemia, including acute hypoglycemic conditions such as those brought on by insulin overdose and the overuse of oral hypoglycemic agents.
| Original language | English |
|---|---|
| Patent number | 5234906 |
| Publication status | Published - 10 Aug 1993 |